Targeting glioblastoma using a novel peptide specific to a deglycosylated isoform of brevican.

Saved in:
Bibliographic Details
Title: Targeting glioblastoma using a novel peptide specific to a deglycosylated isoform of brevican.
Authors: von Spreckelsen N; Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States.; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.; Department of Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital, University of Cologne, 50937 Cologne, Germany., Fadzen CM; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, United States., Hartrampf N; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.; Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland., Ghotmi Y; Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States., Wolfe JM; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, United States., Dubey S; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA02115, United States., Yang BY; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA02115, United States., Kijewski MF; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA02115, United States., Wang S; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA02115, United States., Farquhar C; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, United States., Bergmann S; Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States., Zdioruk M; Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States., Wasserburg JR; Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States., Scott B; Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States., Murrell E; Department of Chemistry, University of Western Ontario, London, ON N6C 4K3 Canada., Bononi FC; Department of Chemistry, University of Western Ontario, London, ON N6C 4K3 Canada., Luyt LG; Department of Chemistry, University of Western Ontario, London, ON N6C 4K3 Canada., DiCarli M; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA02115, United States., Lamfers MLM; Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center, Rotterdam, the Netherlands., Ligon KL; Department of Pathology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States., Chiocca EA; Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States., Viapiano MS; Department of Neuroscience and Physiology, State University of New York Upstate Medical University, Syracuse, New York 13210., Pentelute BL; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, United States., Lawler SE; Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States., Cho CF; Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States.; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Source: Advanced therapeutics [Adv Ther (Weinh)] 2021 Apr; Vol. 4 (4). Date of Electronic Publication: 2021 Jan 20.
Publication Type: Journal Article
Journal Info: Publisher: WILEY-VCH Verlag GmbH & Co. KGaA Country of Publication: Germany NLM ID: 101724632 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2366-3987 (Electronic) Linking ISSN: 23663987 NLM ISO Abbreviation: Adv Ther (Weinh) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2366-3987
DOI:10.1002/adtp.202000244